Suppr超能文献

肝细胞癌:现代影像引导治疗

Hepatocellular carcinoma: modern image-guided therapies.

作者信息

Puppala Sapna, Patel Rafiuddin, Yap Ki Sing, Patel Jai, Wah Tze, Snoddon Andrew

机构信息

Department of Radiology, Leeds Teaching Hospitals, Leeds, UK.

出版信息

Postgrad Med J. 2016 Mar;92(1085):165-71. doi: 10.1136/postgradmedj-2014-132923. Epub 2016 Jan 19.

Abstract

The most common primary malignancy of the liver and the third leading cause of cancer mortality worldwide is hepatocellular carcinoma (HCC), which presents a major global health problem due to its increasing incidence. Most cases of HCC are secondary to either infection (hepatitis B or C) or cirrhosis (alcohol being the most common cause). Clinical presentation is variable and the tumour can be an incidental finding. Treatment options for HCC and prognosis are dependent on many factors but most importantly tumour size and staging. The last two decades have revolutionised the treatment of HCC using image-guided techniques. The concepts of imaging and image-guided techniques are still young and not well described in standard textbooks and hence an up to date review article is essential. The clinical subspecialities may lack familiarity with image-guided techniques but are responsible for management of these patients before and after the treatment by interventional radiologists. This article reviews current image-guided techniques, evidence and outcomes and provides educational highlights and question and answers. The article provides an overview in a simple understandable manner to enable readers from various levels of practice and training to benefit from and apply in their practice.

摘要

肝细胞癌(HCC)是肝脏最常见的原发性恶性肿瘤,也是全球癌症死亡的第三大主要原因,由于其发病率不断上升,它成为了一个重大的全球健康问题。大多数HCC病例继发于感染(乙型或丙型肝炎)或肝硬化(酒精是最常见的原因)。临床表现多样,肿瘤可能是偶然发现的。HCC的治疗选择和预后取决于许多因素,但最重要的是肿瘤大小和分期。在过去的二十年里,使用图像引导技术彻底改变了HCC的治疗方式。成像和图像引导技术的概念仍处于发展阶段,在标准教科书中没有得到很好的描述,因此一篇最新的综述文章至关重要。临床亚专业可能对图像引导技术缺乏了解,但在介入放射科医生治疗前后负责这些患者的管理。本文回顾了当前的图像引导技术、证据和结果,并提供了教育要点和问答。本文以简单易懂的方式进行概述,使来自不同实践和培训水平的读者能够从中受益并应用于他们的实践中。

相似文献

1
Hepatocellular carcinoma: modern image-guided therapies.
Postgrad Med J. 2016 Mar;92(1085):165-71. doi: 10.1136/postgradmedj-2014-132923. Epub 2016 Jan 19.
2
[Hepatocellular carcinoma].
Ther Umsch. 2011 Apr;68(4):213-7. doi: 10.1024/0040-5930/a000153.
3
Natural history of hepatocellular carcinoma.
Ann Ital Chir. 2008 Mar-Apr;79(2):91-7.
4
[Imaging techniques in hepatocellular carcinoma: diagnosis, extension and evaluation of therapeutic response].
Gastroenterol Hepatol. 2010 Dec;33(10):721-6. doi: 10.1016/j.gastrohep.2010.01.012. Epub 2010 May 5.
6
Current treatment for hepatocellular carcinoma.
Clin J Oncol Nurs. 2004 Aug;8(4):393-9. doi: 10.1188/04.CJON.393-399.
7
Hepatocellular carcinoma: diagnostics and screening.
J Eval Clin Pract. 2012 Apr;18(2):335-42. doi: 10.1111/j.1365-2753.2010.01599.x. Epub 2010 Nov 30.
8
Hepatocellular carcinoma: Advances in diagnostic imaging.
Drug Discov Ther. 2015 Oct;9(5):310-8. doi: 10.5582/ddt.2015.01058.
9
Hepatocellular carcinoma: current management and recent advances.
Hepatobiliary Pancreat Dis Int. 2008 Jun;7(3):237-57.
10
[Surgical therapy of hepatocellular carcinoma].
Zentralbl Chir. 2003 Nov;128(11):900-5. doi: 10.1055/s-2003-44796.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验